Eurozone backs Greek reforms, enabling €172bn rescue extensionPublished time: February 24, 2015 09:43Edited time: February 24, 2015 15:03Get short URLReuters / Yves HermanTagsFinance, MarketsGreece’s eurozone creditors have approved the reform plan it put forward, which paves the way for the country’s €172 billion bailout to be extended until June.“National procedures for extension of the Greek programme can begin,” EU Euro […]
Stock Market Trading at New Record High – Will Uptrend Extend Even Further?Stock-Markets / Stock Markets 2015Feb 23, 2015 – 03:51 PM GMTBy: Paul_RejczakBriefly: In our opinion, speculative short positions are favored (with stop-loss at 2,150 and profit target at 1,980, S&P 500 index)Our intraday outlook is bearish, and our short-term outlook is bearish:Intraday outlook (next 24 hours): bearishShort-term outlook […]
If you’re nervous about investing in biotech stocks, you’re not alone.Biotech stocks can be scary. They are based on a lot of hope and promise, and they do appear to traditional investors to have gone too far too fast.In October 2013, The Wall Street Journal ran a story saying that biotech stocks might be too overpriced.Here’s the second paragraph of the […]
All stocks are shorts once the momentum shiftsCRIS – Biotech, Market cap: 294M @ $3.4. S/O: 86M, Float:70M.Initially up on a PR from mid Jan regrading a collaboration with Augenics (who now owns 10% of CRIS). CRIS also has a $120M worth of warrants and stock offerings sitting on the shelf. This is also the 7th offering they’ve made. This […]
The Seven Financial Indicators of Highly Successful Biotech Stocks InvestingCompanies / BioTechFeb 21, 2015 – 10:41 AM GMTBy: Money_MorningErnie Tremblay writes: When evaluating biotech stocks, many key indicators that work for other industries – e.g. price-to-earnings ratio, profit margin, revenue-per-share – often don’t apply.Here’s why they don’t, and why seven of these critical financial indicators do…The Usual Ratios Don’t ApplyThe […]
By Profit Scanner for InvestorPlace MediaHealthcare has been far and away the best sector of 2015 so far — and biotech stocks are no exception.The iShares Nasdaq Biotechnology Index (ETF) (IBB) is up 9.4% in just the year-to-date; that’s about twice the return of the Nasdaq as a whole, and four-and-a-half times more than the S&P 500. And analysts at […]
Why Neuralstem, Inc. Shares Surged Higher
By iCELL News on February 20, 2015 · Investing
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case they’re material to our investing thesis.What: Shares of Neuralstem, Inc (NYSEMKT: CUR ) jumped by as much as 9.6% today after Brean […]
CRNT
CRNT had a big move today on high volume as it shot through resistance at 1.10 and at 1.16. It is now sitting right under multi-month resistance at 1.20 and needs to break that level before moving higher. I do like the potential for this stock if that level is broken – notice how there is not any resistance ahead […]
Sam Ro
Feb. 16, 2015, 2:37 PM
1,035
FactSetSee AlsoThe state of global business conditions in one quoteWhy Americans aren’t spending all the money they’re saving on gasHere’s your complete preview of this week’s big economic eventsIf you thought Wall Street’s forecasts for earnings were too bullish, then congratulations. You were right.Earnings and expectations for earnings growth are arguably the most important drivers […]
Small-cap biotechnology stocks offer some of the most breathtaking opportunities in the market, but some are better than others. For example, these three tiny biotech stocks are favorites among our Motley Fool experts, and that could mean they’re worth watching.Source: Portola Pharmaceuticals.: Warfarin’s decades long dominance as an anticoagulant used to treat heart disease and post-operative patients is waning, and […]
